Search alternatives:
mean decrease » a decrease (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
5 mean » _ mean (Expand Search), a mean (Expand Search), i mean (Expand Search)
50 ng » 50 mg (Expand Search), 10 ng (Expand Search), 5 ng (Expand Search)
mean decrease » a decrease (Expand Search)
ns decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), a decrease (Expand Search)
5 mean » _ mean (Expand Search), a mean (Expand Search), i mean (Expand Search)
50 ng » 50 mg (Expand Search), 10 ng (Expand Search), 5 ng (Expand Search)
-
41
-
42
-
43
-
44
ngLVA degradation kinetics.
Published 2022“…<p>Cos-7 cell infected with L2-euoprom-ngLVA, treated with 34 μg/ml chloramphenicol (CAM) or vehicle only (1:1000 EtOH in RPMI) at 35 hpi (arrow). …”
-
45
-
46
-
47
-
48
-
49
Mean decrease in accuracy (MDA) of top 15 urine metabolites.
Published 2020“…Urine metabolites with a mean decrease in accuracy ≥ 0.004 in at least one post-treatment time point (2–5) were considered for inclusion in the predictive model.…”
-
50
Flow chart of the study procedures.
Published 2023“…The median age was 45 (interquartile range [IQR], 38–50), 98.5% (67/68) were men, and 97.1% (66/68) had HIV. …”
-
51
Spatial representation of mean annual soil loss increase/decrease derived with the different modeling centers (rows) and time steps (columns) with the SSP5-8.5.
Published 2023“…<p>Spatial representation of mean annual soil loss increase/decrease derived with the different modeling centers (rows) and time steps (columns) with the SSP5-8.5.…”
-
52
-
53
-
54
Performance of selected antimalarials against field isolates during the study period.
Published 2024Subjects: -
55
-
56
Performance of selected drugs against field isolates during the study period.
Published 2024Subjects: -
57
Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period.
Published 2024Subjects: -
58
-
59
<i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period.
Published 2024Subjects: -
60